Scott Rothbart

15 results.

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

December 5, 2018 Teaming up to accelerate scientific discovery

How close collaboration between academic labs, the biotech sector and a highly competitive federal grant program bolsters biomedical research innovation and cutting-edge technology…

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…

March 12, 2018 There is no “I” in “team”

When it comes to understanding the intricate genetic architecture that makes us human, the old adage holds true — the whole is greater than the…

September 25, 2017 How getting back to the basics can improve human health

When the DNA double helix was first described more than 60 years ago, it sparked a scientific renaissance.

It was a revolutionary milestone, but it…

VAI DEFAULT HEADER
September 20, 2017 $2.375 million federal award to study epigenetic control systems, inform drug discovery

GRAND RAPIDS, MI (Sept. 20, 2017)—Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing…

November 3, 2016 New computational tool may speed drug discovery

GRAND RAPIDS, Mich. (November 3, 2016)—A new computational tool called fABMACS is helping scientists see beyond static images of proteins to more…